Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-18T04:30:06.495Z Has data issue: false hasContentIssue false
  • English
  • Français

An Immunochemical Approach to Model and Long-Term Suppression of Depressive and Anxiety Behavior

Published online by Cambridge University Press:  10 April 2014

Igor P. Ashmarin ,
Raisa A. Danilova ,
Olga I. Rud'ko ,
Maria V. Belopolskaya ,
Maria F. Obukhova  and
Elena V. Shmalgausen
Igor P. Ashmarin*
Affiliation:
Moscow State University
Raisa A. Danilova
Affiliation:
Moscow State University
Olga I. Rud'ko
Affiliation:
Moscow State University
Maria V. Belopolskaya
Affiliation:
Moscow State University
Maria F. Obukhova
Affiliation:
Moscow State University
Elena V. Shmalgausen
Affiliation:
Moscow State University
*
Correspondence concerning this article should be addressed to: Igor P. Ashmarin, Dept. of Human Physiology, School of Biology, Moscow State University, Vorobiovy Gory, Moscow, 119922, Russia. FAX: (095) 939 33 55. E-mail: ashmarin25@mail.ru
Get access Rights & Permissions [Opens in a new window]

Abstract

The inhibitor of monoaminooxydase isatin and the ligand of B-receptors cholecystokinin-4 play a significant role in the suppression and induction of depressive and anxiety states. We induced the formation of auto-antibodies to these compounds against their conjugates with antigen-carrier by immunization of white rats. The result was long-term (more than 2 months) stimulation of depressive and anxiety behavior after immunization to isatin and, in contrast, the suppression of such behavior after immunization to cholecystokinin. The perspective of immunochemical approach to long-term correction of behavior is discussed.

El inhibidor de la monoaminooxidasa isatin y el ligando de B-receptores colecistokinina-4 juegan un papel significativo en la supresión e inducción de los estados de ansiedad y depresión. Nosotros hemos inducido la formación de auto-anticuerpos contra estas sustancias mediante la inmunización de ratas blancas. El resultado fue la estimulación prolongada (más de 2 meses) de conducta depresiva y de ansiedad tras la inmunización con isatin y, por el contrario, la supresión de esta conducta después de la inmunización con colecistokinina. En el artículo se discute la posibilidad de la corrección de la conducta a largo plazo mediante la manipulación immunoquímica.

Keywords

Depressionmodelingimmuno-correctionactive immunizationcholecystokinin-4isatinbiogenic aminesrats.Depresiónremodelaciónimmuno-correccióninmunización activacolecistokinina-4isatinaminas biogénicasratas.
Type
Articles
Information
The Spanish Journal of Psychology , Volume 9 , Issue 2 , November 2006 , pp. 219 - 227
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arushanyan, E.B., & Bayer, E.B. (2004). Interaktivnoe psychoemotsional'noe sostoyanie I aktivnost' immunoi sistemy [Interactive psycho-emotional states and activity of the immune system], Uspehi Fiziiologiceskih nauk, 35, 49–64.Google Scholar
Ashmarin, I.P., Danilova, R.A., Mashkovskii, M.D., Mel'nic, E.I., Obukhova, M.F., Sagimbaeva, Sh.K., & Zirenina, M.L. (1990). Active immunization against bioregulators: Behavioral and catecholamine changes in albino rats immunized against sydnophen. Biomedical Science, 1, 95–98.Google ScholarPubMed
Ashmarin, I.P., Danilova, R.A., Mel'nik, E.I., Obukhova, M.F., Sagimbaeva, Sh.K., Zirenina, M.L., & Ganzha, S.V. (1989). Immunologicheskoe vmeshatel'stvo v neirokhimicheskie i neiropsikhologicheskie protsessy: katekholaminy, pevedenie i sudorozhnaya gotovnost' belykh krys, immunizirovanykh kon'ugatom seroal'buminom s sidofenom [Immunologic intervention in neurochemical and neurophysiologic processes: Catecholamines, behaviour, and convulsion readiness in white rats immunized with seroalbumin sydnophen conjugate]. Neirokhimia, 8, 328–335.Google Scholar
Ashmarin, I.P., Danilova, R.A., & Obukhova, M.F. (2001). Dlitel'naya korrektsia funktsii mozga, perspektivy immunologicheskikh podkhodov [Protracted correction of brain functions, prospects of immunologic approaches]. Vestnik RAMN, 4, 27–30.Google Scholar
Ashmarin, I.P., Danilova, R.A., Rud'ko, O.I., Obukhova, M.F., & Andreeva, L.A. (2004). Dolgovremennje deistvie peptidnykh regulyatorov, otlozhennye i inversnye effekty kholetsistokinina - 4 i 3. [Long-term action of peptide regulators, delayed and inverse effects of cholecystokinine - 4 and 3]. Medizinskii akademicheskii Zhurnal, 4, 4–13.Google Scholar
Ashmarin, I.P., & Gomazkov, O.A. (1992). Active immunization against neurotransmitters and neuromodulators as a means of long-term correction of physiological function. Sov. Sci. Rev. F. Physiol. Gen. Biol, 5, 1–37.Google Scholar
Banks, W.A., & Kastin, A.J. (1987). Saturable transport of peptides across the blood-brain barrier. Life Science, 41, 1319–1338.CrossRefGoogle ScholarPubMed
Banks, W.A., & Kastin, A.J. (1988). Interactions between the blood-brain barrier and endogenous peptides: emerging clinical implications. American Journal of Medical Science, 295, 459–471.CrossRefGoogle ScholarPubMed
Banks, W.A., & Kastin, A.J. (1990). Peptide transport systems for opiates across the blood-brain barrier. American Journal of Physiology, 259, 1–10.Google ScholarPubMed
Burlet, A.J., Leon-Henri, B.P., Robert, F.R., Arachmani, A., Femette, B.M., & Burlet, C.K. (1987). Monoclonal anti-vasopressin (VP) antibodies penetrate into VP neurons, in vivo. Experimental Brain Research, 65, 629–638.CrossRefGoogle ScholarPubMed
Danilova, R.A., & Ashmarin, I.P. (1994). Inversnaya immunoregulyatsia povedenia I problema suschestvovania regulyatornykh antitel [Inverse immunoregulation and the problem of the existence of regulatory antibodies]. Uspehi Fiziiologiceskih nauk, 25, 3–23.Google Scholar
Danilova, R.A., Belopolskaya, M.V., Kushnir, E.A., Moskvitina, T.A., Afanasjev, I.I., Andiarzhanova, E.A., Obukhova, M.F., Shevchenko, V.P., & Ashmarin, I.P. (2000). Dolgovrmennoe izmenenie biokhumicheskogo i fiziologicheskogo statusa belykh krys immunomodulyatsiei aktivnosti monoaminooksidazy [Long-term changes in biochemical and physiologic states of white rats with immunomodulation of the activity of monoaminooxidase]. Neirokhimia, 17, 192–197.Google Scholar
Danilova, R.A., & Fedorova, I.M. (2001). The effects of immunization against cholecystokinin (30-33) on rats behavior. Federation of American Societies for Experimental Biology, 15, 913.Google Scholar
Danilova, R.A., Moskvitina, T.A., Obukhova, M.F., Belopolskaya, M.V., & Ashmarin, I.P. (1999). Pargyline conjugate-induced long-term activation of monoamine oxidase as an immunological model for depression. Neurochemical Research, 24, 1149–1153.CrossRefGoogle ScholarPubMed
Danilova, R.A., Obukhova, M.F., Ashmarin, I.P., & Mashkovskii, M.D. (1988). Dlitel'noe izmenenie emotsional'nogo stausa i obuchaemosti belykh krys posle immunizatii kon'ugatom sidnofenom s serual'buminom [Protracted alterations in emotional state and learning of white rats following immunization with sydnophen seroalbumin conjugates]. Dokladi AN SSS, 303, 1512–1514.Google Scholar
Danilova, R.A., Obukhova, M.F., Belopolskaya, M.V., & Ashmarin, I.P. (1998). Induktsia dlitel'nogo sostoyaniya depressii (s komponentami trevozhnosti I strakha) immunizirovanykh krys k pargilinu [Induction of protracted depression states (with anxiety and fear components) in rats immunized with pargyline]. Vestnik RAMN, 8, 27–32.Google Scholar
Danilova, R.A., Rud'ko, O.I., Korotkova, T.M., Obukhova, M.F., & Ashmarin, I.P. (2002). The effects of immunization against cholecystokinin fragment 30-33 in the behavior of white rats. Neuroscience and Behavioral Physiology, 32, 189–194.CrossRefGoogle ScholarPubMed
Friedman, E.M., Becker, K.A., Overstreet, D.H., & Lawrence, D.A. (2002). Reduced primary antibody responses in a genetic animal model of depression. Psychosomatic Medicine, 64, 267–273.CrossRefGoogle Scholar
Kosten, T.R., Rosen, M., Bond, J., Settles, M., Roberts, J.S., Shields, J., & Jack, L. (2002). Human therapeutic cocaine vaccine: Safety and immunogenecity. Vaccine, 20, 1196–1204.CrossRefGoogle Scholar
Kryzhanovsky, G.N., Man'kovsky, N.B., Karaban', I.N., & Evseev, V.A (1994). Antitela k serotoninu I ikh vozmozhnaya rol' pri parkinsonizme [Serotonine antibodies and their probable role in Parkinsonism]. Zhurnal Nevropatalogii I psykhiatrii, 94, 21–25.Google Scholar
Leonard, B.E. (2001). The immune system, depression and the action of antidepressants. Progress in Neuro-psychopharmacology and Biological Psychiatry, 25, 767–780.CrossRefGoogle ScholarPubMed
Medvedev, A.E., & Glover, V. (2004). Tribulin and endogenous MAO-inhibitory regulation in vivo. NeuroToxicology, 25, 185–192.CrossRefGoogle ScholarPubMed
Meeker, M.L., Meeker, R.B., & Hayward, J.N. (1987). Accumulation of circulating endogenous and exogenous immunoglobulins by hypothalamic magnocellular neurons. Brain Research, 423, 45–55.CrossRefGoogle ScholarPubMed
Poduslo, J.F., Curran, Q.L., & Berg, C.T. (1994). Macromolecular permeability across the blood-nerve and blood-brain barriers. Proceedings of the National Academy of Sciences of the United States of America, 91, 5705–5709.CrossRefGoogle ScholarPubMed
Relber, H., Kitze, B., Link, M., & Wagner, R. (1988). Cellular immune reactions and blood cerebrosplnal fluid barrier dysfunction in guinea pigs. Neurochem. Res., 13, 463–466.Google Scholar
Stevens, V.S. (1996). Progress in the development of human chorionic gonadotropin antifertility vaccines. American Journal of Reproductive Immunology and Microbiology, 35, 148–155.CrossRefGoogle ScholarPubMed